Endo International Plc (NASDAQ:ENDP) Stock Falls 29% In a Month: But Why?

December 30, 2021

The past few weeks have been a pretty tough time for investors in Endo International Plc (NASDAQ:ENDP) as the company’s stock suffered from a strong selloff. Over the course of the past month, the stock has tanked sharply and gone down by as much as 29%. Trading Data On Wednesday, ENDP stock fell 1.25% to $3.95 with more than 3.29 million shares, compared to its average volume of 7.03 million…

Read More >>

Endo International plc (NASDAQ:ENDP) Stock Gains Momentum: Soars 48% in a Week

October 11, 2021

Endo International plc (NASDAQ:ENDP) was up 12% on Friday and 48% in a month. Recently the company entered an agreement in principle for the settlement of opioid-linked cases and claims of Louisiana and other governmental entities and persons in exchange for a $7.5 million payment. This settlement and the payment are subject to 100% participation by political subdivisions in the state and execution of the definitive documentation. However, the settlement…

Read More >>

Endo International Plc (NASDAQ:ENDP) Stock Bounces Back Strongly After The Big News

September 13, 2021

Endo International Plc (NASDAQ:ENDP) jumped 33% following the rally of its debt on Friday following the settlement of claims by New York regarding its opioid marketing. As a result, the company averted a potential $1 billion verdict and the possibility of being stripped of legal defenses in the ongoing suit in the state. The $50 million settlement announced on Thursday was for allegations that the company’s marketing efforts and sales…

Read More >>

Endo International Plc (ENDP) Stock Continues to Fall: What’s The Buzz

September 9, 2021

In the past month the Endo International Plc (NASDAQ:ENDP) stock has been in the midst of a heavy selloff and during that period, the stock has declined by as much as 52%. While there has been no news about the company so far this month, the decline may be related to the setback that the company received with regards to the patent infringement case against Eagle Pharmaceuticals Inc back on…

Read More >>

Endo International Plc (ENDP) Stock Sees Selling Pressure At Higher Level

September 7, 2021

The previous week was not a particularly great week in the capital markets for Endo International Plc (NASDAQ:ENDP) as the company saw its stock tank by as much as 9% through the period. The company had a setback back on August 31, 2021 when the United States District Court for the District of Delaware ruled that Eagle Pharmaceuticals Inc had not infringed on patents of Endo in relation to the…

Read More >>

Endo International plc (NASDAQ: ENDP) Reports 12% YoY Drop in Q1 2021 Consolidated Revenue

July 26, 2021

Endo International plc (NASDAQ: ENDP)  has reported its Q1 2021 financial results for the period ended March 31, 2021, in which consolidated revenue was $718 million, which is a 12% Yoy drop. The decline was a result of Sterile Injectable and Generic Pharmaceutical segment revenue decrease.  Growing competition affected sales in Q1 2021 Branded pharmaceutical unit revenue was $207 million, with specialty product revenues jumping 7% to 143 million and…

Read More >>